Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Br J Haematol ; 196(2): 390-396, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34562018

RESUMO

In patients with beta-thalassaemia intermedia or major, hepcidin induces iron overload by continuously promoting iron absorption. There have been no studies in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia (IDA), examining whether hepcidin is inhibited by GDF15, as may occur in patients with beta-thalassaemia intermedia or major, or whether the iron metabolism characteristics and the effect of iron supplementation are consistent with simple IDA in pregnancy. We compared and analysed routine blood parameters, iron metabolism parameters, the GDF15 levels, and the hepcidin levels among four groups, namely the beta-thalassaemia (ß) + IDA, ß, IDA, and normal groups. In addition, the ß + IDA and IDA groups received iron supplementation for four weeks. We found no statistically significant correlation between hepcidin and GDF15 in any group, but a positive correlation was observed between hepcidin and ferritin. After iron supplementation, the routine blood parameters and iron metabolism parameters in the ß + IDA group were improved, and the hepcidin content was significantly increased. These results suggest that in pregnant women with beta-thalassaemia minor, hepcidin functions normally to maintain iron homeostasis, and that iron supplementation is effective and safe.


Assuntos
Anemia Ferropriva/complicações , Anemia Ferropriva/terapia , Suplementos Nutricionais , Ferro/administração & dosagem , Complicações Hematológicas na Gravidez/terapia , Talassemia beta/complicações , Adulto , Anemia Ferropriva/diagnóstico , Biomarcadores/sangue , Gerenciamento Clínico , Suscetibilidade a Doenças , Índices de Eritrócitos , Feminino , Humanos , Ferro/efeitos adversos , Gravidez , Complicações Hematológicas na Gravidez/diagnóstico , Complicações Hematológicas na Gravidez/etiologia , Resultado do Tratamento , Talassemia beta/sangue , Talassemia beta/diagnóstico
2.
Nan Fang Yi Ke Da Xue Xue Bao ; 39(8): 998-1002, 2019 Aug 30.
Artigo em Chinês | MEDLINE | ID: mdl-31511223

RESUMO

OBJECTIVE: To explore the effect of mindfulness meditation training for improving anxiety, depression and sleep disorders in perimenopausal women. METHODS: Intervention by menopause meditation training was delivered in 121 perimenopausal women with anxiety, depression or sleep disorders in Baiyun District, Guangzhou. Before and after the intervention, the Self-rating Anxiety Scale, Self-rating Depression Scale and Pittsburg Sleep Quality Index were used for assessment of changes in the conditions of the women. RESULTS: After menopausal meditation training, the perimenopausal women showed significant improvement in the mean scores of Self-rating Anxiety Scale (48.26 ± 6.47; t=3.865, P < 0.01), Selfrating Depression Scale (50.27 ± 6.54; t=4.541, P < 0.01) and Pittsburgh Sleep Questionnaire (10.64 ± 4.38; t=5.596, P < 0.01). The symptom remission rates differed significantly among the women with different self-practice frequencies (P < 0.01). The remission rates of anxiety, depression and sleep disorder increased significantly with the frequency of self-exercise (P < 0.01). CONCLUSIONS: Mindfulness meditation training can effectively alleviate the symptoms of anxiety and depression and improve the quality of sleep in perimenopausal women, and the frequency of the exercise is positively correlated with the improvements. Mindfulness meditation training can be an effective intervention for improving the mental health of perimenopausal women.


Assuntos
Meditação , Atenção Plena , Ansiedade , Depressão , Feminino , Humanos , Perimenopausa , Sono
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA